These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 24988275)
21. Spatiotemporal delivery of basic fibroblast growth factor to directly and simultaneously attenuate cardiac fibrosis and promote cardiac tissue vascularization following myocardial infarction. Fan Z; Xu Z; Niu H; Sui Y; Li H; Ma J; Guan J J Control Release; 2019 Oct; 311-312():233-244. PubMed ID: 31521744 [TBL] [Abstract][Full Text] [Related]
22. Reduced Graphene Oxide-GelMA Hybrid Hydrogels as Scaffolds for Cardiac Tissue Engineering. Shin SR; Zihlmann C; Akbari M; Assawes P; Cheung L; Zhang K; Manoharan V; Zhang YS; Yüksekkaya M; Wan KT; Nikkhah M; Dokmeci MR; Tang XS; Khademhosseini A Small; 2016 Jul; 12(27):3677-89. PubMed ID: 27254107 [TBL] [Abstract][Full Text] [Related]
23. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Garbern JC; Minami E; Stayton PS; Murry CE Biomaterials; 2011 Mar; 32(9):2407-16. PubMed ID: 21186056 [TBL] [Abstract][Full Text] [Related]
24. Enhanced Electroactivity, Mechanical Properties, and Printability through the Addition of Graphene Oxide to Photo-Cross-linkable Gelatin Methacryloyl Hydrogel. Xavier Mendes A; Moraes Silva S; O'Connell CD; Duchi S; Quigley AF; Kapsa RMI; Moulton SE ACS Biomater Sci Eng; 2021 Jun; 7(6):2279-2295. PubMed ID: 33956434 [TBL] [Abstract][Full Text] [Related]
25. Sustained co-delivery of BIO and IGF-1 by a novel hybrid hydrogel system to stimulate endogenous cardiac repair in myocardial infarcted rat hearts. Fang R; Qiao S; Liu Y; Meng Q; Chen X; Song B; Hou X; Tian W Int J Nanomedicine; 2015; 10():4691-703. PubMed ID: 26251592 [TBL] [Abstract][Full Text] [Related]
26. Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats. Salimath AS; Phelps EA; Boopathy AV; Che PL; Brown M; García AJ; Davis ME PLoS One; 2012; 7(11):e50980. PubMed ID: 23226440 [TBL] [Abstract][Full Text] [Related]
27. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354 [TBL] [Abstract][Full Text] [Related]
28. Collagen-targeting vascular endothelial growth factor improves cardiac performance after myocardial infarction. Zhang J; Ding L; Zhao Y; Sun W; Chen B; Lin H; Wang X; Zhang L; Xu B; Dai J Circulation; 2009 Apr; 119(13):1776-84. PubMed ID: 19307480 [TBL] [Abstract][Full Text] [Related]
29. Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. Shyu KG; Wang MT; Wang BW; Chang CC; Leu JG; Kuan P; Chang H Cardiovasc Res; 2002 Jun; 54(3):576-83. PubMed ID: 12031703 [TBL] [Abstract][Full Text] [Related]
30. VEGF nanoparticles repair the heart after myocardial infarction. Oduk Y; Zhu W; Kannappan R; Zhao M; Borovjagin AV; Oparil S; Zhang JJ Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H278-H284. PubMed ID: 29101176 [TBL] [Abstract][Full Text] [Related]
31. Injectable Citrate-Based Hydrogel as an Angiogenic Biomaterial Improves Cardiac Repair after Myocardial Infarction. Yuan Z; Tsou YH; Zhang XQ; Huang S; Yang Y; Gao M; Ho W; Zhao Q; Ye X; Xu X ACS Appl Mater Interfaces; 2019 Oct; 11(42):38429-38439. PubMed ID: 31573790 [TBL] [Abstract][Full Text] [Related]
32. Transdermal regulation of vascular network bioengineering using a photopolymerizable methacrylated gelatin hydrogel. Lin RZ; Chen YC; Moreno-Luna R; Khademhosseini A; Melero-Martin JM Biomaterials; 2013 Sep; 34(28):6785-96. PubMed ID: 23773819 [TBL] [Abstract][Full Text] [Related]
33. Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel. Wu J; Zeng F; Huang XP; Chung JC; Konecny F; Weisel RD; Li RK Biomaterials; 2011 Jan; 32(2):579-86. PubMed ID: 20932570 [TBL] [Abstract][Full Text] [Related]
34. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Hao X; Silva EA; Månsson-Broberg A; Grinnemo KH; Siddiqui AJ; Dellgren G; Wärdell E; Brodin LA; Mooney DJ; Sylvén C Cardiovasc Res; 2007 Jul; 75(1):178-85. PubMed ID: 17481597 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-377 regulates mesenchymal stem cell-induced angiogenesis in ischemic hearts by targeting VEGF. Wen Z; Huang W; Feng Y; Cai W; Wang Y; Wang X; Liang J; Wani M; Chen J; Zhu P; Chen JM; Millard RW; Fan GC; Wang Y PLoS One; 2014; 9(9):e104666. PubMed ID: 25251394 [TBL] [Abstract][Full Text] [Related]
36. Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction. Hu CH; Li ZM; DU ZM; Zhang AX; Yang DY; Wu GF Chin Med J (Engl); 2009 Mar; 122(5):548-55. PubMed ID: 19323906 [TBL] [Abstract][Full Text] [Related]
37. Controlling mechanical properties of cell-laden hydrogels by covalent incorporation of graphene oxide. Cha C; Shin SR; Gao X; Annabi N; Dokmeci MR; Tang XS; Khademhosseini A Small; 2014 Feb; 10(3):514-23. PubMed ID: 24127350 [TBL] [Abstract][Full Text] [Related]
38. An injectable conductive hydrogel encapsulating plasmid DNA-eNOs and ADSCs for treating myocardial infarction. Wang W; Tan B; Chen J; Bao R; Zhang X; Liang S; Shang Y; Liang W; Cui Y; Fan G; Jia H; Liu W Biomaterials; 2018 Apr; 160():69-81. PubMed ID: 29396380 [TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model. Kim SW; Lee DW; Yu LH; Zhang HZ; Kim CE; Kim JM; Park TH; Cha KS; Seo SY; Roh MS; Lee KC; Jung JS; Kim MH Cardiovasc Res; 2012 Sep; 95(4):495-506. PubMed ID: 22886775 [TBL] [Abstract][Full Text] [Related]
40. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium. Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]